
What We're Reading: J&J Pauses Vaccine Trial; Bias in Analytics Software; Fear of COVID-19 Surge
J&J is pausing recruitment for its clinical trial of a coronavirus disease 2019 vaccine; racial bias found in algorithms used nationwide in health-cost analytics software; Americans stockpile food and other essentials amid resurging pandemic fears.
J&J Pauses COVID-19 Vaccine Trial Due to Unexplained Illness
Announced yesterday, Johnson & Johnson (J&J) said it is temporarily pausing recruitment and dosing for its coronavirus disease 2019 (COVID-19) vaccine candidate clinical trial after an unexplained illness in a study participant. Reported by
Bias in Health-Cost Analytics Software
Reported today, a
Americans Stockpiling Amid Fears of COVID-19 Surge
Reported by
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.